Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Glatting

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Potential of optimal preloading in anti-CD20 antibody radioimmunotherapy: an investigation based on pharmacokinetic modelingPeter Kletting, Christoph Meyer, Sven N Reske, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic modelPeter Kletting, Donald Bunjes, Sven N Reske, et al.
EJNMMI Physics|February 9, 2023
Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of conceptDeni Hardiansyah, Ade Riana, Ambros J Beer, et al.
Physics in Medicine and Biology|December 2, 2010
Analysing saturable antibody binding based on serum data and pharmacokinetic modellingPeter Kletting, Hady Kiryakos, Sven N Reske, et al.
Physics in Medicine and Biology|October 13, 2009
Comparing time activity curves using the Akaike information criterionPeter Kletting, Thomas Kull, Sven N Reske, et al.
Zeitschrift Fur Medizinische Physik|August 12, 2022
Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects modelDeni Hardiansyah, Ade Riana, Ambros J Beer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2010
EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetryCecilia Hindorf, Gerhard Glatting, Carlo Chiesa, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D modeThomas Kull, Jochen Ruckgaber, Rolf Weller, et al.
Medical Physics|October 8, 2003
ROC analysis for assessment of lesion detection performance in 3D PET: influence of reconstruction algorithmsGerhard Glatting, Christoph Werner, Sven N Reske, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2002
A survey of PET activity in Germany during 1999Gunnar Brix, Dietmar Nosske, Gerhard Glatting, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Cancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Potential of optimal preloading in anti-CD20 antibody radioimmunotherapy: an investigation based on pharmacokinetic modelingPeter Kletting, Christoph Meyer, Sven N Reske, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic modelPeter Kletting, Donald Bunjes, Sven N Reske, et al.
EJNMMI Physics|February 9, 2023
Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of conceptDeni Hardiansyah, Ade Riana, Ambros J Beer, et al.
Physics in Medicine and Biology|December 2, 2010
Analysing saturable antibody binding based on serum data and pharmacokinetic modellingPeter Kletting, Hady Kiryakos, Sven N Reske, et al.
Physics in Medicine and Biology|October 13, 2009
Comparing time activity curves using the Akaike information criterionPeter Kletting, Thomas Kull, Sven N Reske, et al.
Zeitschrift Fur Medizinische Physik|August 12, 2022
Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects modelDeni Hardiansyah, Ade Riana, Ambros J Beer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2010
EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetryCecilia Hindorf, Gerhard Glatting, Carlo Chiesa, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D modeThomas Kull, Jochen Ruckgaber, Rolf Weller, et al.
Medical Physics|October 8, 2003
ROC analysis for assessment of lesion detection performance in 3D PET: influence of reconstruction algorithmsGerhard Glatting, Christoph Werner, Sven N Reske, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2002
A survey of PET activity in Germany during 1999Gunnar Brix, Dietmar Nosske, Gerhard Glatting, et al.
Pageof 15